Literature DB >> 3700770

Eosinophilic panniculitis: a clinicopathologic study.

R K Winkelmann, E Frigas.   

Abstract

Study of 18 patients with biopsy diagnoses of eosinophilic panniculitis revealed diverse patterns of systemic disease, including Wells' syndrome, vasculitis, atopy, and erythema nodosum as well as localized panniculitis. Significant associated diseases included psychiatric illness, 6 (drug dependency, 4); atopy, 5 (asthma, 3); malignancies, 5; immune complex vasculitis, 4; thyroid disease, 2; Wells' eosinophilic cellulitis, 2; glomerulonephritis and sarcoidosis, 1 each. The skin lesions varied from urticarial papules and plaques to purpura, pustules, and ulcerative lesions but always included a nodular subcutaneous component, frequently as a presenting complaint. Eosinophilic panniculitis is a non-specific finding that can signify localized disease, such as an insect bite or injection lipophagic granuloma in a drug-dependent patient, or systemic lymphoma or immune reactive disease. Eosinophilic panniculitis in erythema nodosum is perhaps its most confusing presentation.

Entities:  

Mesh:

Year:  1986        PMID: 3700770     DOI: 10.1111/j.1600-0560.1986.tb00455.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Acquired platelet dysfunction with eosinophilia: review of seven adult cases.

Authors:  S H Lim; C E Tan; T Agasthian; L S Chew
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

Review 2.  Vasculitis: mechanisms involved and clinical manifestations.

Authors:  Loic Guillevin; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

3.  Normal human adipose tissue functions and differentiation in patients with biallelic LPIN1 inactivating mutations.

Authors:  Michele Pelosi; Eric Testet; Soazig Le Lay; Isabelle Dugail; Xiaoyun Tang; Guillaume Mabilleau; Yamina Hamel; Marine Madrange; Thomas Blanc; Thierry Odent; Todd P W McMullen; Marco Alfò; David N Brindley; Pascale de Lonlay
Journal:  J Lipid Res       Date:  2017-10-06       Impact factor: 5.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.